Enlivex Therapeutics Ownership | Who Owns Enlivex Therapeutics?

Enlivex Therapeutics Ownership Summary

Enlivex Therapeutics is owned by 1.21% institutional investors, 4.53% insiders, and 94.27% retail investors. Millennium management is the largest institutional shareholder, holding 2.98% of ENLV shares. Dolphin 90/10 IL is the top mutual fund, with 0.20% of its assets in Enlivex Therapeutics shares.

ENLV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Enlivex Therapeutics	1.21%	4.53%	94.27%
Sector	Healthcare Stocks	41.87%	10.80%	47.33%
Industry	Biotech Stocks	43.97%	10.75%	45.28%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Millennium management	633.85K	2.98%	$741.60K
Citizens financial group inc/ri	231.42K	0.97%	$240.68K
Morgan stanley	173.63K	0.73%	$180.57K
Renaissance	157.29K	0.66%	$163.58K
Xtx topco	42.67K	0.18%	$44.38K
Two sigma securities	34.24K	0.14%	$35.61K
Sigma investment counselors	28.00K	0.12%	$29.12K
Jane street group	21.53K	0.09%	$22.39M
Hrt financial lp	18.79K	0.08%	$19.00K
Prosperity consulting group	17.65K	0.07%	$18.35K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Two sigma securities	34.24K	0.01%	$35.61K
Citizens financial group inc/ri	231.42K	0.00%	$240.68K
Xtx topco	42.67K	0.00%	$44.38K
Sigma investment counselors	28.00K	0.00%	$29.12K
Prosperity consulting group	17.65K	0.00%	$18.35K
Millennium management	633.85K	0.00%	$741.60K
Activest wealth management	1.00K	0.00%	$1.04K
Renaissance	157.29K	0.00%	$163.58K
Bfsg	1.00K	0.00%	$1.04K
Red tortoise	150.00	0.00%	$156.00

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	633.85K	0.00%	633.85K
Citizens financial group inc/ri	231.42K	0.00%	231.42K
Xtx topco	42.67K	0.00%	42.67K
Two sigma securities	34.24K	0.01%	34.24K
Hrt financial lp	18.79K	0.00%	18.79K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.41M
Citadel advisors	-	-	-55.52K
Morgan stanley	173.63K	-	-45.52K
Jane street group	21.53K	-	-39.52K
Virtu financial	-	-	-17.45K

New Positions

Holder	Shares	% Assets	Change	Value
Millennium management	633.85K	0.00%	633.85K	$741.60K
Citizens financial group inc/ri	231.42K	0.00%	231.42K	$240.68K
Xtx topco	42.67K	0.00%	42.67K	$44.38K
Prosperity consulting group	17.65K	0.00%	17.65K	$18.35K
Susquehanna group, llp	11.16K	-	11.16K	$13.06K

Sold Out

Holder	Change
Qube research	-1.00
Global retirement partners	-11.00
Raymond james financial	-57.00
Barclays	-1.00K
Simplex trading	-1.06K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	12	-40.00%	287,663	-87.72%	1	1.05%	2	-60.00%	1	-83.33%
Jun 30, 2025	22	-21.43%	2,557,493	-19.40%	11	5.56%	5	-44.44%	8	14.29%
Mar 31, 2025	27	3.85%	3,162,878	-7.25%	14	5.62%	8	-55.56%	7	133.33%
Dec 31, 2024	11	-47.62%	53,240	-97.92%	-	0.15%	7	-22.22%	2	-33.33%
Sep 30, 2024	21	10.53%	2,564,823	23.06%	13	10.59%	9	12.50%	3	-40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Dolphin 90/10 IL	43.48K	0.20%	-
MTF TR TA-Growth	37.59K	0.17%	-1.46K
IBI Mehaka TA-Growth	13.30K	0.06%	-80.00
Dolphin Flexible	7.42K	0.03%	-
I.B.I 90/10	5.75K	0.03%	-
Fidelity Nasdaq Composite Index	5.69K	0.02%	-
Harel HTF TA All-Share IL	3.86K	0.02%	9.00
I.B.I Government + 10% IL	3.00K	0.01%	-
Dolphin75/25 IL	787.00	0.00%	-
Metiav 30/70 ESG Model IL	457.00	0.00%	457.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 09, 2015	Murray Michael Anthony	former SVP - Operations	Sell	$156.76K

ENLV Ownership FAQ

Who Owns Enlivex Therapeutics?

Enlivex Therapeutics shareholders are primarily institutional investors at 1.21%, followed by 4.53% insiders and 94.26% retail investors. The average institutional ownership in Enlivex Therapeutics's industry, Biotech Stocks , is 43.97%, which Enlivex Therapeutics falls below.

Who owns the most shares of Enlivex Therapeutics?

Enlivex Therapeutics’s largest shareholders are Millennium management (633.85K shares, 2.98%), Citizens financial group inc/ri (231.42K shares, 0.97%), and Morgan stanley (173.62K shares, 0.73%). Together, they hold 4.68% of Enlivex Therapeutics’s total shares outstanding.

Does Blackrock own Enlivex Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Enlivex Therapeutics.

Who is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested?

Two sigma securities is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 34.24K Enlivex Therapeutics shares, valued at 35.61K$.

Who is the top mutual fund holder of Enlivex Therapeutics shares?

Dolphin 90/10 IL is the top mutual fund holder of Enlivex Therapeutics shares, with 0.20% of its total shares outstanding invested in 43.48K Enlivex Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools